Genome Diagnostics Private Limited - Company overview

Genome Diagnostics is an active private limited company registered with ROC Delhi Ii on 13 November 2003, about 23 years ago.

2003-11-13 New Delhi, Delhi Active Unlisted Active Compliant
Connect MCP

Key Metrics Public MCA facts are exact. Revenue, profit, assets, and employee figures may show as ranges until unlocked.

REVENUE
₹50 Lakh–1 Cr
▼ -9.2%
FY 2023
PROFIT / LOSS
Loss · ₹10–50 Lakh
▲ 42.7%
FY 2023
EBITDA
Loss · Under ₹1 Lakh
▲ 97.9%
FY 2023
NET WORTH
₹50 Lakh–1 Cr
▼ -20.8%
FY 2023
TOTAL ASSETS
₹1–5 Cr
▼ -14.7%
FY 2023
OPEN CHARGES
2
70.71 Lakh
PAID-UP CAPITAL
49.10 Lakh
AUTHORISED CAPITAL
50.00 Lakh
COMPANY AGE
23 Years 0 Months
since 2003-11-13
LAST FILING WITH ROC
2024-03-31
Last AGM: 2024-09-30
ACTIVE GST
2
Updated: 2024-07-13 01:19:04
SATISFIED CHARGES
-
-

Company Health Scores Scores from 0–100 based on filings, compliance signals, financials, and board history on this profile.

Health scores for Genome Diagnostics covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.

Vendor Trust Score Moderate
60/100
Overall counterparty comfort for vendors and customers.
  • Blend of compliance (45), financial health (40), director (95) and company-foundation signals.
  • Operating for 23+ years.
Compliance Score High risk
45/100
Statutory filings, status and regulatory flags.
  • Company status is Active as per MCA.
  • Last balance sheet filed for Mar 2024 - filings look overdue.
Financial Health Score High risk
40/100
Profitability, leverage and liquidity from filed statements.
  • Loss-making in FY 2023.
  • Positive net worth.
Director Risk Score Low risk
95/100
Board strength, DIN status and churn.
  • 2 directors on the board.
  • No disqualified or deactivated DINs on the current board.
Scores are derived from MCA filings, financial statements and public records on this page. Higher is safer. They are indicative, not a credit rating.
360° Intelligence Report: trust score, financial health, credit risk, growth & distress signals - auto-generated from filings. View report →

About Genome Diagnostics Company identity, industry, contact, and registration details from MCA and company records.

Genome Diagnostics is an active private limited company registered with ROC Delhi Ii on 13 November 2003, about 23 years ago. The registered office is at G-167B, G Block, First Floor, Street No. 1, Hari Nagar, New Delhi, Delhi.

In its MCA filings the main business is listed as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, which made up 100% of turnover.

It has two directors: Anita Singhal and Aakanksha Singhal. The longest-serving is Aakanksha Singhal, on the board since 2014; the most recent to join is Anita Singhal, appointed in May 2018. Five former directors are on record; the most recent to leave was Pradeep Kumar Singhal in May 2018.

₹49.1 lakh of its ₹50 lakh authorised capital is paid up (about 98%). Its latest balance sheet on MCA is for the year ending 31 March 2024, and the last AGM was on 30 September 2024. Nothing newer than 2024 shows up here, so it is worth checking the MCA portal for later filings. Two charges (secured loans) are still open, with Hdfc Bank Limited among the lenders.

Healthcare ••••••••
  • Location G-167B, G Block, First Floor, Street No. 1, Hari Nagar, New Delhi, Delhi - 110058
  • Website genomediagnostics.co.in
Legal NameGenome Diagnostics Private Limited
CIN / LLPINU24239DL2003PTC123068
Company No.123068
ClassificationPrivate Limited Indian Non-Government Company
Incorporation Date2003-11-13
Date of AGM2024-09-30
Date of Balance Sheet2024-03-31
Listing StatusUnlisted
ROC CodeRoc Delhi Ii
PAN
LEI Number
Active ComplianceActive Compliant

Current Directors of Genome Diagnostics (2) Current board members from MCA filings, including designation and appointment details.

A
Director | Since 2018-05-12 | DIN: 08112433
A
Director | Since 2014-05-19 | DIN: 06859656

Financial Performance of Genome Diagnostics Bands and Low / Medium / High trend shape. Exact figures unlock with your report.

Estimated bands · FY 2023
Revenue ₹50 Lakh–1 Cr ▼ -9.2%
P&L Loss · ₹10–50 Lakh ▲ 42.7%
EBITDA Loss · Under ₹1 Lakh ▲ 97.9%
Net worth ₹50 Lakh–1 Cr ▼ -20.8%

Exact figures and labelled charts require an active report plan.

Verified entity values are shown only after access is granted.

Charges of Genome Diagnostics Open and satisfied charges registered against the company with MCA.

Others : 60.00 Lakh
Hdfc Bank Limited : 10.71 Lakh
Open Charges: 2 Satisfied Charges: 0
Open 70.71 Lakh
Satisfied 0
LenderAmountStatus
Hdfc Bank Limited
Creation Date: 29 Dec 2021
10.71 Lakh Open
Others
Creation Date: 23 Jan 2006
60.00 Lakh Open

Business Activity Principal business activity and turnover mix from MCA filings.

Activity GroupDescriptionTurnover %
ManufacturingChemical and chemical products, pharmaceuticals, medicinal chemical and botanical products100

Financial Ratios of Genome Diagnostics Profitability, leverage, and liquidity ratios from filed statements. Exact values unlock with your report.

9 years of ratios on record

Profitability, leverage and liquidity ratios require an active report plan.

Net profit margin Debt / Equity Current ratio ROE

Unlock exact ratio values and multi-year insights.

Verified entity values are shown only after access is granted.

Shareholding Pattern of Genome Diagnostics Ownership and contribution detail from filings. Full breakdown unlocks with your report.

8 shareholder categories on record

Ownership mix and contribution history require an active report plan.

Ownership mix Category breakdown Year-wise pattern Promoter holding

Unlock full ownership and contribution details.

Verified entity values are shown only after access is granted.

GST Compliance of Genome Diagnostics GST registrations and filing status by state. Full compliance detail unlocks with your report.

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

GSTIN registrations State-wise filing status HSN and SAC details Tax jurisdiction records

GST registrations and filing compliance require an active report plan.

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Genome Diagnostics Ratings, court records, and regulatory alerts. Full risk detail unlocks with your report.

1 regulatory flag on record

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

Rating history Court and tribunal cases Regulatory alerts Director-linked violations

Credit ratings, litigation, and regulatory alerts require an active report plan.

Verified entity values are shown only after access is granted.

MSME Payment Delays by Genome Diagnostics MSME supplier payment delays and filing history. Full amounts unlock with your report.

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

Outstanding amounts Delay periods and reasons MSME-1 filing history Vendor payment signals

MSME payment history requires an active report plan.

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Genome Diagnostics Official MCA forms, returns, and filing index. Document access unlocks with your report.

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

Incorporation documents Annual returns and statements Charge filings Complete filing index

MCA filings and documents require an active report plan.

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Genome Diagnostics Common questions about this company from MCA and profile data. Some answers are limited until unlocked.
Who is the owner of Genome Diagnostics?
MCA does not publish an "owner" field. Genome Diagnostics is run by its directors, Anita Singhal and Aakanksha Singhal. The people who own the shares are listed in its annual return (form MGT-7), which can differ from the directors.
Who are the current board members and directors of Genome Diagnostics?
Genome Diagnostics has two current directors: Anita Singhal (since May 2018) and Aakanksha Singhal (since May 2014).
What is CIN of Genome Diagnostics?
The CIN of Genome Diagnostics is U24239DL2003PTC123068. Reading it left to right: U means it is not listed, 24239 is the industry code it registered under, DL is Delhi, 2003 is the year it was registered, PTC is the company type and 123068 is its registration number.
When was Genome Diagnostics incorporated?
Genome Diagnostics was incorporated on 13 November 2003 with ROC Delhi Ii. That makes it about 23 years old.
What is the registered address of Genome Diagnostics?
The registered office on MCA records is G-167B, G Block, First Floor, Street No. 1, Hari Nagar, New Delhi, Delhi - 110058.
What is the current status of Genome Diagnostics?
MCA shows Genome Diagnostics as Active, and its last AGM on record was in September 2024.
What is the contact number or email for Genome Diagnostics?
You can post to its registered office at G-167B, G Block, First Floor, Street No. 1, Hari Nagar, New Delhi, Delhi - 110058 and use its website, https://genomediagnostics.co.in.
What industry or business activity is Genome Diagnostics associated with?
Its MCA filings list the main business as chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products (100% of turnover).
What is paid-up capital and authorised share capital of Genome Diagnostics?
Paid-up capital is ₹49.1 lakh and authorised capital is ₹50 lakh, so about 98% of the authorised amount has been issued.
When did Genome Diagnostics last file accounts and hold an AGM?
The last AGM on record was on 30 September 2024, and the latest balance sheet is for the year ending 31 March 2024. Nothing newer than 2024 shows up, so check the MCA portal for later filings.
Where can I see charges and lenders for Genome Diagnostics?
Two charges against Genome Diagnostics are still open. Lenders named in the filings include Hdfc Bank Limited.
Have any directors left Genome Diagnostics?
Yes, five former directors are on record. The most recent to leave were Pradeep Kumar Singhal (May 2018), Shivani Dhole (May 2018) and Sunita Mallick (May 2014).
What is the turnover or revenue of Genome Diagnostics?
Based on filed financial statements, the revenue of Genome Diagnostics for FY 2023 was in the ₹50 Lakh–1 Cr range. That is down 9.2% on the previous year. Exact year-wise revenue, profit and balance sheet figures are on the Financial tab.
What is the net worth of Genome Diagnostics?
For FY 2023, the net worth of Genome Diagnostics was in the ₹50 Lakh–1 Cr range.
How can I get the financial details of Genome Diagnostics?
The latest accounts on record are for FY 2023. The Financial tab has year-wise profit and loss, balance sheet and ratios, with exact figures after you sign in.
What is the official website of Genome Diagnostics?
The website on record for Genome Diagnostics is https://genomediagnostics.co.in.
Which company owns genomediagnostics.co.in?
genomediagnostics.co.in is the website listed for Genome Diagnostics Private Limited in its company records.
Genome Diagnostics - is it listed or unlisted?
Genome Diagnostics is unlisted, so its shares are not traded on a stock exchange. Its CIN starts with U for the same reason.
What is the ROC code of Genome Diagnostics?
Genome Diagnostics is registered with ROC Delhi Ii.
What is the company classification of Genome Diagnostics?
MCA classifies Genome Diagnostics as: Private Limited Indian Non-Government Company.
Does Genome Diagnostics have GST registrations on file?
Yes, 2 active GST registrations are linked to Genome Diagnostics, usually one per state it operates in.

Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.